Iterum Therapeutics plc (ITRM)


Stock Price Forecast

April 17, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Iterum Therapeutics plc chart...

About the Company

We do not have any company description for Iterum Therapeutics plc at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

23

Exchange

Nasdaq

$17M

Total Revenue

23

Employees

$0M

Market Capitalization

-0.47

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ITRM News

Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript

16d ago, source:

Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.02. ITRM isn’t one of the ...

Iterum Therapeutics plc (ITRM)

3d ago, source: Yahoo Finance

Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript March 28, 2024 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.94, expectations were $-1.02.

Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

21d ago, source: Business Insider

--Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE ...

Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript

16d ago, source: InvestingChannel on MSN

Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript March 28, 2024 Iterum Therapeutics plc beats earnings ...

Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

21d ago, source: Stockhouse

DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV ...

Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript

21d ago, source: Seeking Alpha

Hello, everyone, and welcome to the Iterum Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Business Update. My name is Emily, and I'll be coordinating your call today.

Iterum Therapeutics PLC ITRM

25d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Iterum Therapeutics PLC: Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

21d ago, source: Finanznachrichten

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to ...

Q4 2023 Iterum Therapeutics PLC Earnings Call

21d ago, source: Yahoo Finance

Hello, everyone, and welcome to the Iterum Therapeutics fourth quarter and full year 2023 financial results and business update. My name is Emily, and I'll be coordinating your call. (Operator ...

Q4 2023 Iterum Therapeutics PLC Earnings Call

21d ago, source:

Hello, everyone, and welcome to the Iterum Therapeutics fourth quarter and full year 2023 financial results and business update. My name is Emily, and I'll be coordinating your call. (Operator ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...